- Report
- November 2025
- 282 Pages
Global
From €5219EUR$5,850USD£4,565GBP
- Report
- September 2025
- 250 Pages
Global
From €4005EUR$4,490USD£3,504GBP
- Report
- March 2025
- 200 Pages
Global
From €4005EUR$4,490USD£3,504GBP
- Report
- June 2025
- 150 Pages
Global
From €2676EUR$3,000USD£2,341GBP
€3345EUR$3,750USD£2,926GBP
- Report
- December 2024
- 30 Pages
Global
From €1963EUR$2,200USD£1,717GBP
€2453EUR$2,750USD£2,146GBP
- Clinical Trials
- April 2025
- 50 Pages
Global
From €1070EUR$1,200USD£936GBP
€1338EUR$1,500USD£1,170GBP
- Report
- September 2025
- 150 Pages
Global
From €3970EUR$4,450USD£3,472GBP
- Report
- June 2025
- 400 Pages
Global
From €4415EUR$4,949USD£3,862GBP
- Report
- September 2025
- 112 Pages
Global
From €3500EUR$4,203USD£3,169GBP
- Report
- May 2021
- 50 Pages
China
From €2319EUR$2,600USD£2,029GBP
- Report
- November 2023
- 135 Pages
Global
From €3568EUR$4,000USD£3,121GBP
- Report
- September 2024
- 343 Pages
Global
From €5674EUR$6,360USD£4,963GBP
€7092EUR$7,950USD£6,204GBP
- Report
- July 2024
- 150 Pages
Global
From €2676EUR$3,000USD£2,341GBP
€3345EUR$3,750USD£2,926GBP
- Report
- April 2023
- 117 Pages
Global
From €4237EUR$4,750USD£3,707GBP
- Report
- May 2024
- 137 Pages
Global
From €4928EUR$5,524USD£4,311GBP
€5798EUR$6,499USD£5,071GBP
- Report
- January 2023
- 85 Pages
Europe
From €1338EUR$1,500USD£1,170GBP
- Report
- March 2023
- 147 Pages
Global
From €4415EUR$4,949USD£3,862GBP
- Report
- January 2024
- 156 Pages
United States
€3390EUR$3,800USD£2,965GBP
- Report
- January 2024
- 114 Pages
United States
€3122EUR$3,500USD£2,731GBP
- Report
- July 2018
- 33 Pages
Global
From €8921EUR$10,000USD£7,803GBP

Tiotropium is a long-acting anticholinergic drug used to treat chronic obstructive pulmonary disease (COPD). It is a bronchodilator, meaning it relaxes the muscles in the airways, allowing more air to flow in and out of the lungs. It is available in both an inhaler and a dry powder inhaler. Tiotropium is the only long-acting anticholinergic approved for the treatment of COPD. It is also used to treat asthma and other respiratory conditions.
Tiotropium is a popular drug in the respiratory drugs market, as it is effective in treating COPD and other respiratory conditions. It is also well-tolerated, with few side effects. It is available in both generic and brand-name forms, making it accessible to a wide range of patients.
Some companies in the Tiotropium market include Boehringer Ingelheim, GlaxoSmithKline, and Novartis. Show Less Read more